NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer
June 15, 2020Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer
Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …
AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients
June 15, 2020Sales and Marketing AbbVie, leukaemia
AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …
Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million
June 12, 2020Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale
Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …
Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July
June 12, 2020Medical Communications COVID-19, coronavirus
Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The …
Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes
June 12, 2020Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes
Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …
Top Ten most popular articles on Pharmafile.com this week
June 12, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing coronavirus, top 10
The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …
Coronavirus has caused widespread disruption to cancer care in England
June 12, 2020Medical Communications COVID-19, coronavirus
Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs …
Study finds that MDMA has long-term benefits for treating PTSD
June 11, 2020Business Services MDMA, PTSD
PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing …
MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer
June 11, 2020Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure
MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …
Eli Lilly’s coronavirus antibody treatments could be available by September
June 11, 2020Business Services COVID, COVID-19, coronavirus
An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …
AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn
June 11, 2020Research and Development AbbVie, Genmab, partnership, pharma
AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …
Leading pharmaceutical companies sued in US for conspiring to drive up generics prices
June 11, 2020Business Services drugs, generics, lawsuit, price fixing, price-fixing
26 pharmaceutical companies are being sued by most US states for allegedly conspiring to reduce competition and drive up generic …
How digital therapeutics are revolutionising healthcare
June 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma
Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …
Ex-GSK exec named as Chief Medical Officer at Immatics Biotechnologies
June 10, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment, immatics
Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …
Number of people waiting for NHS treatment could double to 10 million due to pandemic
June 10, 2020Research and Development COVID-19, coronavirus
The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …
Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents
June 10, 2020Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma
Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …
Pharmafile.com’s weekly COVID-19 news round-up
June 10, 2020Research and Development COVID-19, coronavirus, round up, top 10
Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …
Lundbeck to restructure R&D, shedding up to 160 jobs
June 10, 2020Manufacturing and Production, Research and Development Lundbeck, pharma, staff cuts
Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a …
US trial of ivermectin cuts coronavirus mortality by 40%
June 10, 2020Research and Development COVID-19, coronavirus
A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%. …
EMA could approve Gilead’s streamlined remdesivir application for COVID-19 “within weeks”
June 9, 2020Manufacturing and Production, Sales and Marketing COVID-19, EU, Gilead, coronavirus, remdesivir
The European Medicines Agency has received the application from Gilead for the first conditional marketing authorisation (CMA) of its antiviral …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
